Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Danova

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|April 4, 2017
Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical TrialsAntonio Bernardo, Raffaella Palumbo, Rebecca Pedersini, et al.
Leukemia & Lymphoma|April 7, 2010
Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of lifeEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Oncology Reports|March 17, 2009
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphomaPaolo G Gobbi, Francesco Valentino, Marco Danova, et al.
Tumori|April 4, 2013
Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based surveyDiego Cortinovis, Giordano Beretta, Elena Piazza, et al.
Tumori|October 25, 2014
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian StudyDaniele Fagnani, Luciano Isa, Magda Franca Verga, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.
Tumori|February 15, 2020
Health technology assessment-based approach to flow cytometric immunophenotyping of acute leukemias: a literature classificationGiuseppe Gaipa, Eugenio Erba, Marco Danova, et al.
BMC Cancer|June 15, 2011
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancerFotios Loupakis, Annamaria Ruzzo, Lisa Salvatore, et al.
Clinical Genitourinary Cancer|January 1, 2020
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Graziella Pinotti, Lorenza Bertù, et al.
The Oncologist|March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune DisordersAndrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|April 4, 2017
Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical TrialsAntonio Bernardo, Raffaella Palumbo, Rebecca Pedersini, et al.
Leukemia & Lymphoma|April 7, 2010
Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of lifeEsther N Oliva, Francesco Nobile, Giuliana Alimena, et al.
Oncology Reports|March 17, 2009
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphomaPaolo G Gobbi, Francesco Valentino, Marco Danova, et al.
Tumori|April 4, 2013
Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based surveyDiego Cortinovis, Giordano Beretta, Elena Piazza, et al.
Tumori|October 25, 2014
Granulocyte colony-stimulating factors used in clinical practice: PoloNord Registry-Based Cohort Italian StudyDaniele Fagnani, Luciano Isa, Magda Franca Verga, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.
Tumori|February 15, 2020
Health technology assessment-based approach to flow cytometric immunophenotyping of acute leukemias: a literature classificationGiuseppe Gaipa, Eugenio Erba, Marco Danova, et al.
BMC Cancer|June 15, 2011
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancerFotios Loupakis, Annamaria Ruzzo, Lisa Salvatore, et al.
Clinical Genitourinary Cancer|January 1, 2020
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Graziella Pinotti, Lorenza Bertù, et al.
The Oncologist|March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune DisordersAndrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
Pageof 8